Insider Transactions in Q3 2022 at Angiodynamics Inc (ANGO)
Insider Transaction List (Q3 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jul 29
2022
|
Dave Helsel SVP Global Operations and R&D |
SELL
Open market or private sale
|
Direct |
5,000
-17.35%
|
$110,000
$22.44 P/Share
|
|
Jul 20
2022
|
James C Clemmer President and CEO |
BUY
Grant, award, or other acquisition
|
Direct |
33,094
+6.99%
|
-
|
|
Jul 20
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Grant, award, or other acquisition
|
Direct |
3,987
+9.55%
|
-
|
|
Jul 20
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Grant, award, or other acquisition
|
Direct |
3,426
+7.96%
|
-
|
|
Jul 20
2022
|
Dave Helsel SVP Global Operations and R&D |
BUY
Grant, award, or other acquisition
|
Direct |
3,691
+11.35%
|
-
|
|
Jul 20
2022
|
Laura Piccinini SVP International |
BUY
Grant, award, or other acquisition
|
Direct |
4,402
+37.44%
|
-
|
|
Jul 20
2022
|
Richard C Rosenzweig SVP and General Counsel |
BUY
Grant, award, or other acquisition
|
Direct |
3,963
+19.03%
|
-
|
|
Jul 20
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Grant, award, or other acquisition
|
Direct |
7,961
+8.25%
|
-
|
|
Jul 20
2022
|
Scott Centea SVP/GM, VIT |
BUY
Grant, award, or other acquisition
|
Direct |
3,705
+7.03%
|
-
|
|
Jul 20
2022
|
Michael E Tarnoff |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+20.07%
|
-
|
|
Jul 20
2022
|
Karen A Licitra |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+16.71%
|
-
|
|
Jul 20
2022
|
Howard W Donnelly |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+5.94%
|
-
|
|
Jul 20
2022
|
Wesley Johnson |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+7.41%
|
-
|
|
Jul 20
2022
|
Dennis S Meteny |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+5.43%
|
-
|
|
Jul 20
2022
|
Jan Stern Reed |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+12.42%
|
-
|
|
Jul 20
2022
|
Eileen O'Shea Auen |
BUY
Grant, award, or other acquisition
|
Direct |
7,060
+12.49%
|
-
|
|
Jul 15
2022
|
Wesley Johnson |
SELL
Payment of exercise price or tax liability
|
Direct |
4,505
-5.26%
|
$94,605
$21.32 P/Share
|
|
Jul 15
2022
|
Wesley Johnson |
BUY
Exercise of conversion of derivative security
|
Direct |
6,022
+6.56%
|
$90,330
$15.95 P/Share
|
|
Jul 15
2022
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,398
-13.34%
|
$260,358
$21.32 P/Share
|
|
Jul 15
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
14,758
+13.7%
|
$221,370
$15.95 P/Share
|
|
Jul 12
2022
|
Dennis S Meteny |
SELL
Payment of exercise price or tax liability
|
Direct |
4,798
-3.97%
|
$95,960
$20.02 P/Share
|
|
Jul 12
2022
|
Dennis S Meteny |
BUY
Exercise of conversion of derivative security
|
Direct |
6,022
+4.75%
|
$90,330
$15.95 P/Share
|
|
Jul 07
2022
|
Dave Helsel SVP Global Operations and R&D |
SELL
Payment of exercise price or tax liability
|
Direct |
1,223
-4.64%
|
$24,460
$20.54 P/Share
|
|
Jul 07
2022
|
Dave Helsel SVP Global Operations and R&D |
BUY
Exercise of conversion of derivative security
|
Direct |
3,480
+11.66%
|
-
|
|
Jul 07
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
SELL
Payment of exercise price or tax liability
|
Direct |
1,078
-3.09%
|
$21,560
$20.54 P/Share
|
|
Jul 07
2022
|
Chad Thomas Campbell SVP/GM, Vascular Access |
BUY
Exercise of conversion of derivative security
|
Direct |
3,104
+8.18%
|
-
|
|
Jul 07
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
SELL
Payment of exercise price or tax liability
|
Direct |
919
-2.48%
|
$18,380
$20.54 P/Share
|
|
Jul 07
2022
|
Warren Nighan Jr SVP Quality and Regulatory |
BUY
Exercise of conversion of derivative security
|
Direct |
3,233
+8.01%
|
-
|
|
Jul 07
2022
|
Stephen A Trowbridge EVP and CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
1,509
-1.89%
|
$30,180
$20.54 P/Share
|
|
Jul 07
2022
|
Stephen A Trowbridge EVP and CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
4,188
+4.99%
|
-
|
|
Jul 07
2022
|
James C Clemmer President and CEO |
SELL
Payment of exercise price or tax liability
|
Direct |
8,574
-2.06%
|
$171,480
$20.54 P/Share
|
|
Jul 07
2022
|
James C Clemmer President and CEO |
BUY
Exercise of conversion of derivative security
|
Direct |
25,123
+5.7%
|
-
|